- Title
- Changes in Tumor Blood Flow as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) May Predict Activity of Single Agent Bevacizumab in Recurrent Epithelial Ovarian (EOC) and Primary Peritoneal Cancer (PPC) Patients: An exploratory analysis of a Gynecologic Oncology Group Phase II study
- Creators
- Dana M. Chase (Author) - Creighton UniversityMichael W. Sill (Author)Bradley J. Monk (Author) - Creighton UniversityMark D. Chambers (Author)Kathleen M. Darcy (Author)Ernest S. Han (Author)Barbara J. Buening (Author)Joel I. Sorosky (Author)John P. Fruehauf (Author)Robert A. Burger (Author)
- Additional links
- http://dx.doi.org/10.1016/j.ygyno.2012.06.002
- Publication Details
- Gynecologic Oncology, Vol.126(3), pp.375-380
- Number of pages
- 375-380
- Identifiers
- 991005931888002656
- Academic Unit
- School of Medicine; Obstetrics & Gynecology
- Resource Type
- Journal article
Journal article
Changes in Tumor Blood Flow as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) May Predict Activity of Single Agent Bevacizumab in Recurrent Epithelial Ovarian (EOC) and Primary Peritoneal Cancer (PPC) Patients: An exploratory analysis of a Gynecologic Oncology Group Phase II study
Gynecologic Oncology, Vol.126(3), pp.375-380
09/2012
PMID: 22683587
Metrics
4 Record Views